United States Biotechnology & Medical Research

Instil Bio Inc (TIL)

Track

Track

The most recent insider activity occurred on September 10, 2025, involving CFO and CBO Sandeep Laumas. These transactions consisted of multiple sales and a proposed sale totaling 60,000 shares. Prior to this, significant buying activity was recorded in March 2021 by various stakeholders and executives.
Ticker: TIL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Laumas Sandeep CFO and CBO Officer
Transaction date
Sale
Price
162.14
Quantity 73,489 +9.0%
Value US$2,463,912
3.3
Laumas Sandeep CFO and CBO Officer
Transaction date
Sale
Price
436.62
Quantity 95,618 +22.9%
Value US$4,779,555
3.3
SANDEEP LAUMAS Officer Officer
Transaction date
Proposed sale
Price
16.69
Quantity 13,001
Value US$253,704
Curative Ventures V LLC Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 450,000 +1.2%
Value US$9,000,000
2.4
Shah Nimish P Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 19,620 +inf%
Value US$392,400
2.4
Shah Nimish P Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 48,390 +inf%
Value US$967,800
2.4
Shah Nimish P Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 116,880 +24.3%
Value US$2,337,600
2.4
Shah Nimish P Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 10,470 +1.9%
Value US$209,400
2.4
Shah Nimish P Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 104,640 +1.9%
Value US$2,092,800
Crouch Bronson CEO and Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 450,000 +1.2%
Value US$9,000,000
2.3
Nielsen Jack Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 300,000 +2.5%
Value US$6,000,000
1.5
Vivo Capital IX, LLC Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 300,000 +2.5%
Value US$6,000,000
McGaughy R Kent Jr Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 450,000 +5.6%
Value US$9,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-12 2025-09-10 S Sale
3.3
Laumas Sandeep

CFO and CBO

Officer
73,489 +9.0%
162.14
US$2,463,912 		73,489 +9.0% 162.14 US$2,463,912
2025-09-12 2025-09-10 S Sale
3.3
Laumas Sandeep

CFO and CBO

Officer
95,618 +22.9%
436.62
US$4,779,555 		95,618 +22.9% 436.62 US$4,779,555
2025-09-10 2025-09-10 PrS Proposed sale
3.3
SANDEEP LAUMAS

Officer

Officer
13,001
16.69
US$253,704 		13,001 16.69 US$253,704
2021-03-25 2021-03-23 B Purchase
Curative Ventures V LLC
Large shareholder
450,000 +1.2%
20.00
US$9,000,000 		450,000 +1.2% 20.00 US$9,000,000
2021-03-25 2021-03-23 B Purchase
2.4
Shah Nimish P
Non-Executive Director
19,620 +inf%
20.00
US$392,400 		19,620 +inf% 20.00 US$392,400
2021-03-25 2021-03-23 B Purchase
2.4
Shah Nimish P
Non-Executive Director
48,390 +inf%
20.00
US$967,800 		48,390 +inf% 20.00 US$967,800
2021-03-25 2021-03-23 B Purchase
2.4
Shah Nimish P
Non-Executive Director
116,880 +24.3%
20.00
US$2,337,600 		116,880 +24.3% 20.00 US$2,337,600
2021-03-25 2021-03-23 B Purchase
2.4
Shah Nimish P
Non-Executive Director
10,470 +1.9%
20.00
US$209,400 		10,470 +1.9% 20.00 US$209,400
2021-03-25 2021-03-23 B Purchase
2.4
Shah Nimish P
Non-Executive Director
104,640 +1.9%
20.00
US$2,092,800 		104,640 +1.9% 20.00 US$2,092,800
2021-03-25 2021-03-23 B Purchase
Crouch Bronson

CEO and Chairman

Executive Director Large shareholder
450,000 +1.2%
20.00
US$9,000,000 		450,000 +1.2% 20.00 US$9,000,000
2021-03-25 2021-03-23 B Purchase
2.3
Nielsen Jack
Non-Executive Director
300,000 +2.5%
20.00
US$6,000,000 		300,000 +2.5% 20.00 US$6,000,000
2021-03-25 2021-03-23 B Purchase
1.5
Vivo Capital IX, LLC
Large shareholder
300,000 +2.5%
20.00
US$6,000,000 		300,000 +2.5% 20.00 US$6,000,000
2021-03-25 2021-03-23 B Purchase
McGaughy R Kent Jr
Non-Executive Director
450,000 +5.6%
20.00
US$9,000,000 		450,000 +5.6% 20.00 US$9,000,000
Explore more

More insider trading research around Instil Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America